https://ymaho.com/innovative-therapy-for-hemophilia-and-fabry-disease-in-the-high-cost-nosologies-program
The Ministry of Health Commission will consider lonocotocog alfa and pegunigalsidase alfa for the High-Cost Nosologies program. Find out why inclusion is important for patients and what obstacles have arisen.